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Abstract 
Purpose: To investigate the effect of the aqueous extract of Zingiber officinale Roscoe. (ZOA) rhizome 
on the activity and expression of matrix metalloproteinase (MMP)-2, MMP-9, tissue inhibitor of 
metalloproteinase (TIMP)-1 and TIMP-2 using an in vitro model of Dengue virus (DV) infection. 
Methods: Z. officinale rhizomes were extracted with water by continuous shaking for 5 days. The total 
phenolic content in extract was measured by Folin-Ciocalteu method. High performance liquid 
chromatography (HPLC) was employed to define qualitative and quantitative content of [6]-gingerol in 
ZOA. The median inhibitory concentration (IC50) value of ZOA for Vero cells was determined by 3-(4,5 
dimethylthiazol-2- yl)-2,5-diphenyltetrazolium bromide (MTT) assay. To induce MMPs production, Vero 
cells were infected with DV3. The modulatory effect of ZOA on the activity and expression of MMP-2, 
MMP-9, TIMP-1 and TIMP-2 were assessed using gelatin zymography and quantitative Real-time 
polymerase chain reaction (RTPCR), respectively. 
Results: The yield of the ZOA was 7.98%. Total phenolics in ZOA was 68.17 ± 0.28 mg GAE/g of 
extract and it contained 29.32 ± 1.97 mg 6-gingerol/g of extract.The half-maximal inhibition 
concentration (IC50) of ZOA was 348.8 µg/mL for Vero cells. DV infection of Vero cells significantly 
elevated the production of soluble gelatinolytic MMP-2 and to a lesser extent, MMP-9, and their 
activities were significantly inhibited by ZOA in a dose-dependent manner. A significant down-regulation 
of MMP-2, MMP-9 mRNA expression and up-regulation of TIMP-1, TIMP-2 mRNA expression were 
observed in DV-infected Vero cells following treatment with ZOA, and it occurred in a dose-dependent 
manner.   
Conclusion: The findings of this study  suggest that ZOA may ameliorate plasma leakage in dengue 
virus infection and decrease the chances of severe dengue complications, dengue haemorrhagic fever 
(DHF) and dengue shock syndrome (DSS) by inhibiting the activities and expression of MMP-2 and 
MMP-9 while upregulating the expression of  TIMP-1 and TIMP-2. 
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Dengue is one of the most serious infectious 
diseases in the tropical areas of Asia, Africa and 
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the Americas [1]. Infection by any of the four 
serotypes of dengue viruses (DV-1, -2, -3 and -4) 
may result in either a relatively benign fever, 
called dengue fever (DF), a fatal disease, such 
as dengue haemorrhagic fever (DHF) or dengue 
shock syndrome (DSS) [2]. DV infection causes 
an estimated 100 million new cases of DF, 500 
000 cases of DHF and 25 000 deaths annually 
[3].  
 
Disease severities following DV infection are 
caused by increased vascular permeability 
leading to hypovolemic shock. Matrix 
metalloproteinases (MMPs) are believed to play 
a key role in promoting such severities.  MMPs 
are zinc-dependent endopeptidases and 
comprise a large family of enzymes with different 
abilities to degrade specific extracellular matrix 
(ECM) components [4,5].  The role of MMP-2 
and MMP-9 produced by DV-infected cells in 
inducing in vitro endothelial cell monolayer 
permeability and vascular leakage in mice has 
been established [6,7]. Moreover, significant 
elevation of circulating MMP-9 and MMP-2 in 
dengue patients and their association with 
disease severity and plasma leakage compared 
to healthy controls is well established [8,9]. The 
tissue inhibitor of metalloproteinases (TIMP) 
family, including TIMP-1, TIMP-2, TIMP-3 and 
TIMP-4, regulates the multifunctional 
metalloproteinase activities. TIMPs inhibit MMP 
activities and modulate critical signaling 
pathways independent of metalloproteinase 
inhibition [10]. DV infection enhanced the 
production of TIMP-1 and TIMP-2 but do not 
restore the physiological balance between the 
MMP and TIMP leading to vascular permeability 
[4,5,11]. 
 
In Asian countries, ginger (Zingiber officinale 
Roscoe) has been used as a herbal medicine to 
treat a wide range of disorders such as 
inflammation, dyspepsia, nausea, vomiting, pain, 
the common cold and diarrhoea [12]. 
Phenylpropanoid-derived compounds including 
6-gingerol and shogaols are biologically active 
components present in ginger.  They are 
reported to be effective against in vitro model of 
various disease conditions by modulating the 
secretion, activity and expression of MMP-2 and 
MMP-9 [13-17]. However, the efficacy of ginger 
extracts in modulating MMP and TIMP cellular 
response in DHF/DSS has not been explored. 
Currently, there is neither an approved vaccine 
nor any anti-viral drug available for prevention 
and treatment of dengue and patients are treated 
only symptomatically [18,19].  In this study we 
evaluated the modulatory effect of Z. officinale 
rhizome aqueous extract on activity and 
expression of MMP-2, MMP-9, TIMP-1 and 
TIMP-2. The findings of this study may indicate 
the potential of ginger extract for clinical use in 
DV infection, which may perhaps decrease the 
chance of severe dengue complications, DHF 




Collection and preparation of aqueous extract  
 
Z. officinale rhizomes used in this study were 
collected from the local supplier of Klondykes 
Tuba, Benguet, Philippines and were 
authenticated at National Museum, Manila, 
Philippines. Voucher specimens were processed 
at the laboratory of Research and Biotechnology 
Division of St. Luke’s Medical Center, Quezon 
City, Philippines. The rhizomes were then 
cleaned, peeled and cut into sections of 2 ± 1 
mm thickness followed by drying at 60 oC and 
grinding in a blender until a fine powder was 
produced. The powder obtained was packed in 
polyethylene bags and stored in a refrigerator at 
4 °C for further uses. The extraction protocol 
used was adopted from optimized procedures of 
the antiviral study group of Research and 
Biotechnology Division, St. Lukes Medical 
Center. Thirty grams of powdered rhizome was 
kept in the flask filled with 350 mL of water and 
was subjected for continuous shaking for five 
days. The plant-water suspension was 
centrifuged at 15000 rpm for 20 min at 4 oC. 
Supernatant was filtered. The filtrate was then 
collected and evaporated to near dryness using a 
rotary evaporator (Heidolph WB 2000) at 300 
mmHg at 70 oC and lyophilized to obtain Z. 
officinale rhizomes aqueous extract (ZOA). Two 
batches of 30 g powdered samples were 
extracted and extracts from two batches were 
pooled together to avoid batch-to-batch 
variations. 
  
Determination of total phenolic contents and 
[6]-gingerol content in ZOA 
 
Weighed amount of lyophilised ZOA was 
dissolved in water to a concentration of 3 mg/mL. 
Total phenolic constituents of ZOA were 
determined by utilizing the Folin–Ciocalteu 
reagent, in accordance to a method of Loh et al 
with gallic acid as standard [20]. The total 
phenolic content was determined from a gallic 
acid calibration curve and expressed as mg of 
gallic acid equivalent (GAE) per gram of extract. 
All measurements were performed at least in 
triplicate, and presented as mean ± SD.  
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The standards and samples were filtered through 
a 0.22 µm syringe filter before injecting onto high 
performance liquid chromatography (HPLC) 
system, adopted from Loh et al [20]. The 
contents of 6-gingerol in the extracts was 
analyzed by HPLC using Spectra HPLC system 
(TSP, USA) equipped with P2000 binary pump, 
AS1000 autosampler, UV2000 UV detector and 
SW4000 system controller. ZOA (20 μL) was 
subjected to HPLC for the 6-gingerol analysis. 
Separation was performed on a Lichrospher R18 
(250 mm x 4.6 mm, 5 micron 100A Luna 5u R18 
column) from Phenomenex USA by maintaining 
the isocratic binary flow rate (1 ml/min) using a 
mixture of HPLC grade acetonitrile and water 
(55:45 v/v). The compounds were identified and 
quantified based on retention times using 6-
gingerol as HPLC external standard which was 
purchased from Sigma–Aldrich (USA) (Cat. No. 
29150-4) [21]. A standard curve of the different 
concentrations of 6-gingerol at 25, 50,100, 200, 
400 and 800 μg/mL was prepared. The 
concentration of 6-gingerol in the ZOA was 
determined by linear regression.  
 
Cell culture and dengue virus propagation 
 
C6/36 cells, BHK-21 and Vero cells were 
obtained from the Research and Biotechnology 
Division (RBD), St. Lukes Medical Center, 
Philippines. Vero cells were grown and 
maintained in minimum essential medium (MEM) 
containing 10 % fetal bovine serum (FBS) in a 5 
% CO2 incubator at 37 °C. C6/36 cells were 
grown and maintained in MEM containing 10 % 
FBS at 28 oC in the absence of CO2. The clinical 
isolate of DV3 (strain SLMC-50) was obtained 
from RBD and was propagated in C6/36 cells, as 
previously described with slight modification [22].  
 
DV3 was titrated by foci forming assay as 
described previously by Zandi with slight 
modification [23]. Briefly, a BHK-21 [C-13] cell 
monolayer was prepared in 96 wells cell culture 
microplate. After attaining ~80 % confluency, 
growth medium was removed and the cells were 
infected by DV-3 (100 µL of serially diluted 
infected culture fluid) for 2 h to allow virus 
attachment and penetration into the host cell. 
Thereafter, the wells were overlaid with 2 % 
carboxymethylcellulose in Eagle’s Minimum 
Essential Medium (2 % CMC-EMEM) and 
incubated for 48 h at 37 °C and 5 % CO2. 
  
Following incubation, wells were washed 
carefully with 1x phosphate buffered saline until 
residual CMC-EMEM was completely removed. 
Thereafter, 5 % formaldehyde (JK Baker, USA) 
was added to fix the cells for 2 h at room 
temperature (RT)  followed by washing (three 
times) with PBS. Fixed cells were permeabilized 
using 50 µL of 1 % Nonidet P-40 (Sigma-Aldrich, 
Singapore) for 1 h. The cells were washed three 
times with PBS and blocked using 50 µL of 
BlockAceTM (Wako, Japan) for 1 h. Following 
blocking of nonspecific sites and another three 
washing with PBS, 50 µL of 1:10 dilution of 
dengue virus-specific monoclonal antibody, clone 
6B9, (Dengue Research Group, RBD-SLMC) 
was used to detect the presence of viral 
antigens. The reaction was allowed to take place 
for 1 h at RT.  
 
The cells were then washed three times with 
PBS and incubated with goat anti-rabbit IgG 
conjugated with horse-radish peroxidase (HRP) 
at final concentration of 1:100 (Calbiochem, 
USA) as a secondary antibody for 1 h at RT. 
Finally, 50 µL of 3,3'-diaminobenzidine (DAB) 
peroxidase substrate (Biorad, USA) was added 
to each well to stain the virus foci. 
Immunostaining of infected cells was monitored 
for 5 to 10 min. When color development was 
observed, the reaction was stopped by filling 
wells with 200 µL of distilled water. Viral foci 
were viewed, counted and photographed using 
Olympus CKX41 inverted microscope equipped 
with DP21 camera and expressed as Foci-
Forming-Unit (FFU).          
 
MTT cytotoxicity assay 
 
Cytotoxicity of the ZOA was determined using 
MTT assay as previously described with slight 
modifications [24]. Briefly, monolayers of Vero 
cells were seeded in 96-well microplates and 
treated with different concentrations of ZOA in 
triplicates. Cells were treated for three days at 37 
°C. At the end of the incubation period, 100 μL of 
MTT (Sigma-Aldrich, Singapore) in MEM (0.5 
mg/mL) solution was added to each well. The 
microplate was kept at 37 °C for 4 h followed by 
adding solubilization solution/stop mix to each 
well. The optical density of the wells was 
measured at 570 nm using 96-well plate reader 
(Dynex Technologies Microplate Reader, USA). 
Median Inhibitory Concentration (IC50) values 
were generated from the dose-response curve 
using Graphpad Prism 6. All final concentrations 
of ZOA for treatment were adjusted based on the 
IC50. Bleomycin Sulfate was used as positive 
control. Negative control was treated with media 
alone (without any inhibitors). 
 
Infection of Vero cells with DV3 and 
collection of conditioned media (CM) 
 
Infection of cells with DV3 and collection of CM 
was performed according to a method described 
previously by Luplertlop and Misse with slight 
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modifications [7]. Monolayer of 2.5 × 105 cells/mL 
was exposed to DV3 at multiplicity of infection 
(MOI) of 1 ffu/cell for 4 h to allow the virus to 
adsorp with gently shaking of flasks every 30 
min, washed twice to remove excess virus, and 
further cultured at 37 oC with 5 % CO2 for 24 h in 
MEM, without FBS. The conditioned cell culture 
media from DV-infected Vero cells were collected 
in sterile 15-mL conical tubes and was 
concentrated by size exclusion ultrafiltration 
using AmiconTM-4 Centrifugal Filter Units 
(Millipore). Thus obtained conditioned media 
were aliquoted in 1.5 mL micro-centrifuge tubes 
and were stored at -20 oC until use. All 
experiments were performed using virus-free 
(negative reverse transcription–PCR [25] 
concentrated CM. 
 
Determination of MMP activity by gelatin 
zymography 
 
Substrate gel zymography of the activity of MMP-
2 and MMP-9 was performed with a Mini-Protein 
II apparatus (Bio-Rad), according to a method 
described previously [26,27]. 
 
The concentrated CM was re-suspended in 5X 
sample buffer; 3.72 mL 1 M Tris-HCl pH 6.8, 0.6 
mL 1 % bromophenol blue (Sigma-Aldrich, 
Singapore) in distilled water, 1.68 mL distilled 
water, 6 mL glycerol (Invitrogen, USA)]. Sample 
in buffer 15 μL was loaded in alternating well. 
Four μL of BenchMarkTM Protein Ladder 
(Invitrogen, USA) was used as a molecular 
weight marker. Running conditions were as 
follows: 70 V for the first 30 min and increased to 
100 V until the loaded samples were run at least 
¾ of the gel. After electrophoresis, the gels were 
soaked in 2.5 % Triton X-100 (3 × 20 min) in a 
plastic container at room temperature and placed 
in a mechanical rotator for gentle agitation 
followed by rinsing in distilled water. For 
gelatinase inhibition assays, ZOA and 
Epigallocatechin-3-gallate (EGCG) were freshly 
solubilized in the incubation buffer used for 
developing the zymogram; the gel slab was cut 
into slices corresponding to the lanes which were 
put in different tanks and incubated at 37 °C for 
20 h in the 10 mL of incubation buffer, containing 
6.67 mL of 1.5 M Tris-HCl buffer (pH 8.8), and 
0.4 g CaCl2• 2H2O and 0.02 % Brij-58 filled to 
100 mL with distilled H2O without ZOA (control 
without inhibitor) or with ZOA (6.25, 12.5, 25 and 
50 μg/mL) and 100 μM of EGCG. After 
incubation, the developing buffer was decanted 
and the slabs were stained for 15-30 min in 0.1 
% (w/v) Coomassie blue R-250 in 30 % methanol 
and 10 % acetic acid, and de-stained in the same 
solution without the Coomassie blue dye for 10-
30 min. After de-staining, a light translucent band 
over a blue background was detected for 
gelatinase activity. Gel band images were 
captured by a digital camera and were analyzed 
for optical density through the Image Lab 
(Biorad). Gelatinase proteins that pass across 
the gel matrix digest the gelatin substrate 
incorporated in the gel such that MMP-2 and 
MMP-9 can be detected at 67 kDa and 92 kDa 
as clear zones against the dark background 
[28,29]. EGCG was tested for MMPs inhibitory 
activity as a control since green tea polyphenols 
caused a strong inhibition of the gelatinolytic 
activities of MMP-2 and MMP-9, and of the 
elastinolytic activity of MMP-12 through the 
compound EGCG [30]. In order to determine the 
type of gelatinase observed on the zymograms, 
10 mM ethylenediaminetetraacetic acid (EDTA) 
was added to the buffer during the incubation 
period. All procedures were performed as they 
were for gels without EDTA in the incubation 
buffer. 
 
Real-time RT-PCR for MMP-2, MMP-9, TIMP-1 
and TIMP-2 mRNA 
 
The levels of MMP-2, MMP -9, TIMP-1 and 
TIMP-2 gene expression were analyzed with real 
time RT-PCR as described previously with slight 
modifications [31]. RNA was extracted from Vero 
cells which were seeded at a density of 5 × 104 
cells/mL and infected with DV3 (MOI of 1 ffu/cell) 
for 48 h at 37 °C in presence and absence of 
various concentrations of ZOA and 100 μM 
EGCG. After 48 h, the cells were collected by 
centrifugation (1500 rpm, 5 min, 4 °C) and total 
RNA was extracted using RNeasyTM mini kit 
(Qiagen, Germany) according to the 
manufacturer’s protocol. cDNA was prepared 
from 1 μg of the total RNA using iScriptTM 
Reverse Transcription Supermix for RT-qPCR 
(Bio-Rad Laboratories Inc., Hercules, CA, USA) 
according to the manufacturer’s protocol. 
Subsequent Real-timePCR amplification was 
perfomed using SsoFastTM EvaGreen®Supermix 
(Bio-Rad Laboratories Inc., Hercules, CA, USA) 
according to the manufacturer’s instruction. The 
PCR was run for denaturation at 94 °C for 3 min 
followed by 45 cycles, consisted of denaturing at 
94 °C for 30S, annealing step for 45S (at 56 °C 
for MMP-2 and GAPDH, 59 °C for MMP-9, 60 oC 
for TIMP-1 and TIMP-2) and extension step (at 
72 °C for 30S), followed by a final elongation 
step (at 72 °C for 1 min) [6,32]. The PCR primers 
were used for amplifying MMPs and TIMPs are 




Statistical analysis was carried out using 
GraphPad Prism 6 software. All the results were 
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expressed as Mean ± Standard Deviation (SD). 
The statistics were performed by comparing 
results from treated DV infected cells with 
untreated DV infected cells control using 
Analysis of Variance (ANOVA) followed by 
Dunnett’s Multiple Comparison Test for 





Total phenolic and 6-gingerol contents of 
ZOA 
 
The dry extract weight of ZOA was 4.790 g, 
giving a yield of 7.98 %. As assessed by the 
Folin–Ciocalteu’s method, the total phenolic 
content of the extract was presented as GAE 
with reference to the gallic acid standard curve (y 
= 0.0012x + 0.0126, R2 = 0.9992) plotted using 
the average absorbance values of triplicate sets 
of data against concentrations of gallic acid in 
mg/mL. ZOA contained total phenolics of 68.07 ± 
0.16 mg GAE/g of the extract.   
 
HPLC chromatogram of ZOA is shown in Figure 
1. B and ZOA contained 29.04 ± 2.63 mg 6-
gingerol/g extract. 
 
Table 1: Primers used for amplifying MMPs and TIMPs 
 
Gene Forward primer (5'-3) Reverse primer (5'-3) Reference 
MMP-2 AGGATCATTGGCTACACACC AGCTGTCATAGGATGTGCCC [6] 
MMP-9 CGCAGACATCGTCATCCAGT GGATTGGCCTTGGAAGATGA [6] 
TIMP-1  GCAACTCCGGACCTTGTCATC AGCGTAGGTCTTGGTGAAGC [32] 
TIMP-2 GTAGTGATCAGGGCCAAAG TTCTCTGTGACCCAGTCCAT [32] 






Figure 1:  6-Gingerol content of ZOA. A) Typical HPLC chromatogram of A) Overlay of 6-gingerol standards (25, 
50, 100, 200, 400 and 800 µg/mL); B) ZOA (3 mg/mL) in 55:45(v/v) acetonitrile-water mobile phase 
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Cytotoxicity of ZOA against Vero cells  
 
The IC50 of ZOA was 348.8 µg/mL for Vero cells 
when added directly to the cells (Figure 2). The 
assay demonstrated that 50 µg/mL ZOA exerted 
no significant effects on cell viability and this 





Figure 2: Cytotoxicity of ZOA on Vero cells. MTT 
assay was used to evaluate the cytotoxicity of the 
ZOA. All experiments were conducted in triplicates 
 
DV infection of Vero cells triggers 
overproduction of MMP-2 and MMP-9 
 
DV infection significantly enhanced MMP-2 
proteolytic activity at 67 kDa (band corresponded 
to the molecular weight of MMP-2) and MMP-9 at 
92 kDa (band corresponded to the molecular 
weight of pro-MMP-9) to a lesser extent with p < 
0.0001 compared to non-infected cells. This 
enhancement was reduced after treatment with 
EDTA (metalloproteinase inhibitor, Figure 3). 
 
Inhibitory effect of ZOA on DV-induced MMP-
2 and MMP-9 activities 
 
The activities of MMP-2 and MMP-9 in CM 
collected from DV-infected Vero cells were 
decreased by ZOA treatment in dose-dependent 
manner (Figure 4). 100 µM EGCG significantly 
reduced the DV-induced MMP-2 and MMP-9 
activities. At the ZOA concentration of 6.25 
µg/mL treatment, no difference observed in the 
MMP-2 activity compared to the untreated CM. 
MMP-2 activity was reduced significantly to 88.7 
(p = 0.0243), 38.3 and 16.3 % (p < 0.0001) in 
response to ZOA-treatment with concentrations 
of 12.5, 25 and 50 µg/mL respectively. Similarly, 
there was no difference observed in MMP-9 
activity at CM treated with 6.25 and 12.5 µg/mL 
of ZOA while the activity of MMP-9 was 
significantly reduced to 58.3 % and 34.0 % (p < 
0.0001) in response to ZOA-treatment with 25 
and 50 µg/mL respectively. MMP-2 and MMP-9 
activities were reduced to 34.3 and 28.5 % (p < 





Figure 3:  Detection of proteolytic activity of MMP-2 
and MMP-9 in CM collected from DV infected Vero 
cells. (A) Using 8 % gelatin-zymography (1-4), 
showing the ladder (BenchMarkTM, Invitrogen) (1), 
Concentrated CM from non-infected cells (2), 
concentrated CM from DV infected cells (3). 
Concentrated CM from DV infected cells treated with 
10 mmol/l EDTA (4). (B) Quantitative analysis of the 
bands. Each bar represents the mean ± S.D. 
calculated from three independent experiments; **** 
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Figure 4: Dose dependent inhibition of MMP-2 and MMP-9 activity after treatment with ZOA. (A) Photograph of 
the MMP bands, which are representative of three independent experiments (A). Quantitative analysis of the 
bands for MMP-2 and MMP-9 respectively (B and C). Each bar represents the mean ± S.D. calculated from three 
independent experiments are indicated by not significant (ns), p < 0.05 (*) and p < 0.0001 (****) 
Sharma et al 
Trop J Pharm Res, August 2015; 14(8): 1378  
 
ZOA transcriptionally regulates MMP-2, MMP-
9, TIMP-1 and TIMP-2 
 
The expression of MMP-2, MMP-9 was 
decreased while the expression of TIMP-2 and 
TIMP-1 were increased with an increased 
concentration of ZOA, whereas that of the 
internal control (GAPDH) remained unchanged 
(Figure 5). At the ZOA concentration of 6.25 
µg/mL no difference observed in the MMP-2 
gene expression levels. MMP-2 was reduced to 
0.87 (p =0.0036), 0.56, and 0.19 folds (p < 
0.0001) in response to ZOA treatment at 
concentrations of  12.5 µg/mL 25 µg/mL and 50 
µg/mL respectively while 100 µM of EGCG 
(Control) significantly reduced the expression of 
MMP-2 to 0.82 folds (p = 0.0002) (Figure 5. A). 
At 6.25 and 12.5 µg/mL no difference observed 
in the MMP-9 expression levels. The expression 
of MMP-9 was significantly down-regulated to 
0.82 (p = 0.0001) and 0.76 (p < 0.0001) in 
response to ZOA treatment of 25 and 50 µg/ml 
respectively. 100 µM EGCG significantly down-
regulated the expression of MMP-9 to 0.78 folds 
(p < 0.0001) (Figure 5B). 
 
There was significant increase in the expression 
level of the TIMP-1 gene in the ZOA treated DV 
infected cells with 12.5, 25 and 50 µg/mL to 1.93, 
2.66- and 3.07-fold (p < 0.0001) respectively 
(Figure 5C). Similarly expression of TIMP-2 gene 
was increased to 1.92, 3.86 and 4.78 folds in 
ZOA-treated cells with 12.5, 25 and 50 µg/ml 
respectively. No difference was observed at 6.25 
µg/mL of ZOA treatment. EGCG significantly 
upregulated the expression of TIMP-1 to 1.34 
fold and TIMP-2 to 2.13 folds in comparison to 




Despite tremendous research efforts for its 
control and treatment, there is neither vaccine 
nor specific treatment available for dengue fever, 
and patients are currently treated only 
symptomatically. The main strategy for 
combating dengue infection is through control of 
the mosquito vector population. On the other 
hand, vaccine development has been hampered 
by the complexities of the pathogen itself, the 
four antigenically distinct serotypes, and the 
likelihood that immune enhancement is playing a 
role in disease pathogenesis. Therefore studies 
of novel therapeutic strategies are needed to 
improve the clinical outcome of DV infection. The 
role of MMP-2 and MMP-9 in vascular leakage 
associated with DHF and MMP regulation by 
TIMPs has been established [6-9]. Control of 
MMPs and TIMPs activity is of great significance 
in preventing vascular leakage caused by 
dengue virus (DV) infection. Ginger (Z. officinale 
rhizome) is one of the most frequently and 
heavily consumed dietary condiments throughout 
the world [33]. Biologically active compounds of 
ginger, including 6-gingerol and shogaols were 
reported to be effective against in vitro model of 
various disease conditions by modulating the 
MMP-2 and MMP-9 gene activity, protein 
expression and secretion [14-17]. However, the 
efficacy of Z. officinale rhizome extracts in 
modulating MMPs and TIMPs cellular response 
in DHF/DSS has not been hitherto explored.  
 
In this study, it has been demonstrated that DV 
infection significantly enhanced MMP-2 
proteolytic activity and MMP-9 to a lesser extent. 
This enhancement was reduced after treatment 
with EDTA (metalloproteinase inhibitor). These 
data confirmed that these enzymes are 
metalloproteinases as these proteinases are 
dependent upon calcium for their optimal activity, 
and hydrolyse gelatin. 
 
We investigated the inhibitory effects on the 
gelatinolytic activity of MMP-2 and MMP-9 by 
aqueous extract from rhizomes of Z. officinale, 
and by known MMPs inhibitor, such as EGCG. 
Proteolytic activity was indicated by the presence 
of clear bands on a dark background and the 
intensity of the band was shown to be 
proportional to activity of MMP-2 and MMP-9. 
Results from this study demonstrate dose-
dependent inhibition of MMP-2 and MMP-9 
activities by ZOA in conditioned media collected 
from DV-infected Vero cells as demonstrated by 
gelatin zymography. Likewise, results presented 
here confirmed that Z. officinale rhizome 
aqueous extract has strong concentration- 
dependent modulatory activity on mRNA 
expression of MMP-2, MMP-9, TIMP-1 and 
TIMP-2. Indeed ZOA significantly downregulated 
the mRNA expression of MMP-2 and MMP-9, 
whereas it up regulated the expression of TIMP-1 
and TIMP-2 in DV infected cells in dose-
dependent manner as demonstrated by real time 
RT-PCR.  
 
The anti-MMPs activity of Z. officinale rhizome 
extract has been attributed to its naturally 
occurring compounds such as gingerols and 
shoagols.  In this study, the amount of total 
phenolics in ZOA was 68.07 ± 0.16 mg GAE/g of 
extract and it contained 29.04 ± 2.63 mg 6-
gingerol/g of extract.  The increase in the total 
phenolics content and 6-gingerol with increase in 
concentration of the extract may account for the 
concentration-dependent modulatory activities of  
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Figure 5: Concentration-dependent modulatory effects of ZOA on expression of MMPs and TIMPs in DV infected 
Vero cells. (A) MMP-2, (B) MMP-9, (C) TIMP-1, (D) TIMP-2. Vero cells were plated at a density of 5x 104 cells/mL 
with MEM supplemented with 2 % FBS and infected with DV3 for 48 h at 37 °C in presence and absence of 
various concentrations of ZOA and 100µM EGCG. For quantitative analysis, total RNA was isolated and RT 
followed by real time PCR was performed to investigate the gene expression level. Each bar represents the 
mean ± S.D. calculated from three independent experiments with GAPDH used as the internal control. Columns, 
mean (n = 3); bars, SD. (#) p < 0.05 versus control (noninfected cells), p = not significant (ns), p < 0.01 (**), p < 
0.001(***) and p < 0.0001 (****), statistically significant compared with DV-infected untreated control 
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ZOA on MMPs and TIMPs activities and mRNA 
expression. 
 
Our observations of modulatory effect of ZOA on 
MMPs and TIMPs activity and expression are 
supported by previous findings. Lee et al 
demonstrated that 6-gingerol inhibited metastasis 
through dose dependent inhibition of cell 
adhesion, invasion, motility and activity of MMP-2 
and MMP-9 in MDA-MB-231 human breast 
cancer cells [15]. Similarly, Weng et al showed 
that 6-shogaol and 6-gingerol exerted anti-
invasive activity against hepatoma cells through 
regulation of MMP-9 and TIMP-1 in a dose 
dependent manner [17]. Kim and Kim also 
suggested that 6-gingerol inhibited the 
invasiveness of pancreatic cancer (PANC-1) 
cells by decreasing the levels of protease, MMP-
2, and MMP-9 [34]. All these reports supported 
our findings that the natural compounds such as 
6-gingerol, present in Z. officinale rhizomes, play 




The aqueous extract of Z. officinale rhizome may 
play an important role in the regulation of plasma 
leakage in dengue infection and decrease the 
chances of severe dengue complications by 
inhibiting the activity and expression of MMP-2 
and MMP-9 while upregulating the expression of 
TIMP-1 and TIMP-2. Therefore, it can help in the 
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